Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind active-controlled trial of a recombinant zoster vaccine (CHO cells) in adults aged 40 years and older
CTR20243978Phase 2Active
- Sponsor
- Huanuotai Bio
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Zoster vaccine recombinant in herpes zoster (HZ), Varicella zoster infection, sponsored by Huanuotai Bio. Started Oct 2024; status: active.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)Varicella zoster infection
Beyond the preview
Go deeper on CTR20243978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243978.